XENOPORT
Dr Reddy’s Laboratories inks US licensing pact with XenoPortDr Reddy’s Laboratories will pay an upfront fee of $50 million to XenoPort and up to $440 million on achievement of certain milestones.
Dr Reddy's signs US licensing agreement with XenoPortDr Reddy's Laboratories said it is planning to develop XP23829 as a potential treatment for moderate-to-severe chronic plaque psoriasis.
- Load More